AU2002218084A1 - Inhibitors of thromboxane formation and action - Google Patents
Inhibitors of thromboxane formation and actionInfo
- Publication number
- AU2002218084A1 AU2002218084A1 AU2002218084A AU1808402A AU2002218084A1 AU 2002218084 A1 AU2002218084 A1 AU 2002218084A1 AU 2002218084 A AU2002218084 A AU 2002218084A AU 1808402 A AU1808402 A AU 1808402A AU 2002218084 A1 AU2002218084 A1 AU 2002218084A1
- Authority
- AU
- Australia
- Prior art keywords
- inhibitors
- action
- thromboxane formation
- thromboxane
- formation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24674400P | 2000-11-09 | 2000-11-09 | |
US60/246,744 | 2000-11-09 | ||
US29975201P | 2001-06-22 | 2001-06-22 | |
US60/299,752 | 2001-06-22 | ||
PCT/CA2001/001607 WO2002038157A2 (en) | 2000-11-09 | 2001-11-09 | Inhibitors of thromboxane formation and action |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002218084A1 true AU2002218084A1 (en) | 2002-05-21 |
Family
ID=26938185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002218084A Abandoned AU2002218084A1 (en) | 2000-11-09 | 2001-11-09 | Inhibitors of thromboxane formation and action |
Country Status (4)
Country | Link |
---|---|
US (1) | US8071654B2 (en) |
AU (1) | AU2002218084A1 (en) |
CA (1) | CA2427774C (en) |
WO (1) | WO2002038157A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1509229B1 (en) * | 2002-05-28 | 2009-09-23 | Pace- Asciak, Cecil R. | Compositions comprising hepoxilin analogs and their use in the treatment of cancer |
EP1604668A1 (en) * | 2004-06-03 | 2005-12-14 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Hepoxilins and modulators of ichthyin for treating skin disorders |
WO2006106438A2 (en) * | 2005-01-11 | 2006-10-12 | Evolva Sa | Modulators of ppar activity |
RU2449999C2 (en) * | 2006-01-18 | 2012-05-10 | Эвольва Са | Ppar modulators |
CA2643972C (en) | 2006-04-19 | 2012-01-03 | Peter Demin | Hepoxilin analog enantiomers |
WO2008089463A2 (en) * | 2007-01-18 | 2008-07-24 | Evolva Sa | Substituted 1,3-dioxanes and their uses |
CN114560753B (en) * | 2020-11-27 | 2024-04-26 | 深圳千越生物科技有限公司 | Process for preparing hydroxy epoxy analogues |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0691963B1 (en) * | 1993-03-29 | 1998-07-15 | HSC Research and Development Limited Partnership | Hepoxilin analogs useful as anti-inflammatory agents |
US5783564A (en) * | 1993-12-24 | 1998-07-21 | Mitsubishi Chemical Corporation | Sialic acid derivatives |
US5789441A (en) | 1996-02-15 | 1998-08-04 | Virocell Inc. | Leukotriene B4 as an antiviral and anti-neoplastic agent |
US6093742A (en) * | 1997-06-27 | 2000-07-25 | Vertex Pharmaceuticals, Inc. | Inhibitors of p38 |
US6391305B1 (en) * | 1997-09-10 | 2002-05-21 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
WO1999059578A1 (en) | 1998-05-19 | 1999-11-25 | Research Development Foundation | Triterpene compositions and methods for use thereof |
KR100325581B1 (en) | 1998-08-07 | 2002-08-24 | 오우택 | Analgesic compositions containing substances that result from lipoxygenase metabolism of arachidonic acid |
CA2393904C (en) * | 1999-08-04 | 2012-10-16 | Hsc Research And Development Limited Partnership | Hepoxilin analogs |
US6673785B1 (en) * | 1999-08-04 | 2004-01-06 | Cecil R. Pace-Asciak | Use of hepoxilins or hepoxilin analogs as antidiabetics, antiinflammatory agents |
EP1509229B1 (en) | 2002-05-28 | 2009-09-23 | Pace- Asciak, Cecil R. | Compositions comprising hepoxilin analogs and their use in the treatment of cancer |
-
2001
- 2001-11-09 AU AU2002218084A patent/AU2002218084A1/en not_active Abandoned
- 2001-11-09 US US10/416,132 patent/US8071654B2/en not_active Expired - Fee Related
- 2001-11-09 CA CA2427774A patent/CA2427774C/en not_active Expired - Lifetime
- 2001-11-09 WO PCT/CA2001/001607 patent/WO2002038157A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20040132705A1 (en) | 2004-07-08 |
WO2002038157A2 (en) | 2002-05-16 |
CA2427774A1 (en) | 2002-05-16 |
WO2002038157A3 (en) | 2003-02-27 |
US8071654B2 (en) | 2011-12-06 |
CA2427774C (en) | 2013-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001264729A1 (en) | Thromboxane inhibitors, compositions and methods of use related applications | |
GB0025782D0 (en) | Use of inhibitors | |
AU2001259864A1 (en) | Dynamic adaptive tenuring of objects | |
AU2001258771A1 (en) | -secretase inhibitors | |
AU2001249670A1 (en) | Substituted thiazoles and the use thereof as inhibitors of plasminogen activatorinhibitor-1 | |
AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
AU8969601A (en) | New use of lipase inhibitors | |
AU2001285750A1 (en) | Urokinase inhibitors | |
AU2002213346A1 (en) | Osteopontin-coated surfaces and methods of use | |
AU8235601A (en) | Dispenser and method of use | |
AU2002337913A1 (en) | Glycosulfopeptide inhibitors and methods of use thereof | |
AU5417100A (en) | Product dispenser and method of making same | |
AU2001255696A1 (en) | Telomerase inhibitors and methods of their use | |
AU2002218084A1 (en) | Inhibitors of thromboxane formation and action | |
AUPQ629000A0 (en) | Inhibition of fungi | |
AU2001277889A1 (en) | Veneer-based product and method of manufacture | |
AU2002338734A1 (en) | Use of phosphorodiesterase IV inhibitors | |
AU2001258533A1 (en) | Construction of dies | |
AU2002214038A1 (en) | Inhibitors of transglutaminases | |
AU2002222933A1 (en) | Inhibitors of factor xa | |
AU2001261496A1 (en) | Luxo-sigma54 interactions and methods of use | |
AU2001293557A1 (en) | New inhibitors of iapp fibril formation and uses thereof | |
AU2001251631A1 (en) | Hydrazide and alkoxyamide angiogenesis inhibitors | |
AU2002221882A1 (en) | Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors | |
AU2002222927A1 (en) | Method of making hydrofluorocarbons |